Previous studies show that the C-DIM compounds DIM-C-pPhOH and DIM-C-pPhCO2Me bind NR4A1 and act as NR4A1 antagonists for transactivation assays in colon cancer cells [16] and therefore these compounds were also used in this study on RMS cells. Here, NR4A1 is linked to malignant colon neoplasm.